Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures
Clinical Infectious Diseases · 03.05.2023 · 76 (9) · 1550-1558
DOI: 10.1093/cid/ciac952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 19.12.2022. Verfasst von Patricia J Simner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Drug Resistance, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
We assessed how laboratories use and handle reporting of results of rapid diagnostics performed on positive blood culture broths, with a focus on antimicrobial resistance (AMR) markers.
Methods
A survey assembled by the Antibacterial Resistance Leadership Group Diagnostics Committee was circulated from December 2020 to May 2021. The survey was sent to local hospitals, shared on the ClinMicroNet and Division C listservs, and included in a College of American Pathologists proficiency testing survey.
Results
Ninety-six laboratories of various sizes across the United States (95%) and outside of the United States (5%) participated. Of the laboratories that had at least 1 rapid diagnostic in place (94%), significant heterogeneity in methods used and reporting practices was found across community (52%) and academic (40%) laboratories serving hospitals of various sizes. Respondents had implemented 1 to 6 different panels/platforms for a total of 31 permutations. Methods of reporting rapid organism identification and AMR results varied from listing all targets as “detected”/“not detected” (16–22%) without interpretive guidance, to interpreting results (23–42%), or providing therapeutic guidance comments to patient-facing healthcare teams (3–17%).
Conclusions
Current approaches to reporting molecular AMR test results from positive blood culture vary significantly across clinical laboratories. Providing interpretative comments with therapeutic guidance alongside results reported may assist clinicians who are not well-versed in genetic mechanisms of AMR. However, this is currently not being done in all clinical laboratories. Standardized strategies for AMR gene result reporting are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
- Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Förderung
- NCATS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Johns Hopkins
- Institute for Clinical and Translational Research
- National Center for Advancing Translational Sciences
Zitieren
APA
Simner, P. J., Dien Bard, J., Doern, C., Kristie Johnson, J., Westblade, L., Yenokyan, G., Patel, R., Hanson, K. E., & Antibacterial Resistance Leadership Group (2023). Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures. Clinical Infectious Diseases, 76(9), 1550-1558. https://doi.org/10.1093/cid/ciac952
Vancouver
Simner PJ, Dien Bard J, Doern C, Kristie Johnson J, Westblade L, Yenokyan G, et al. Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures. Clinical Infectious Diseases. 2023;76(9):1550-1558. doi:10.1093/cid/ciac952
BibTeX
@article{Simner2023,
author = {Simner, Patricia J and Dien Bard, Jennifer and Doern, Christopher and Kristie Johnson, J and Westblade, Lars and Yenokyan, Gayane and Patel, Robin and Hanson, Kimberly E and Antibacterial Resistance Leadership Group, Antibacterial Resistance Leadership Group},
title = {Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {76},
number = {9},
pages = {1550--1558},
doi = {10.1093/cid/ciac952}
}
EUVIMED